– Telehealth Watch List
– 2021 Psychedelic Investor Guide out Wednesday.
– Report: Ehave Inc (EHVVF) Our Favorite Small Psychedelic Company
– Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide
– OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
– Billion Dollar Aggregators Buying Mom-and-Pop Amazon Sellers. Simply Amazing.
– Telehealth Watch List
We Haven’t Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.
Highlights on three we find uncommonly interesting.
1. Mitesco (MITI)
2. CB Scientific (CBSC)
3. Biotricity (BTCY)
It’s been tough sailing for most of the players in the sector during 2021. Teledoc(TDOC) for example, was at one point was worth $48 billion. But it then fell from $308 to $131, wiping out $28 billion in market value in the process!
We own both the best performer, Mitesco (MITI) up 900% and the worst performer CB Scientific (CBSC) down 85%.
Read More
2021 Psychedelic Investor Guide out Wednesday.
We’re going balls deep on Psychedelic Stocks. Not to brag but we shine when it comes to identifying new sectors before they ignite, and in 40 years we have never seen a better opportunity than this. There is a powerful combination of sector related skepticism, and FDA related news in the near future, which should diffuse the skepticism – creating a powder keg of opportunity.
This provides an opportune entry point today. This is for long-term investors, but we expect the Robinhood crowd show up after FDA looks at the effectiveness psychedelics is having in treating billion dollar markets related to depression, anxiety, PTSD and even suicide. Buh-bye to Prozac? We’re betting the time is near!
Don’t forget we launched the Internet Stock Review in 1998, the Biotech Stock Review in 2002, the Beverage Stock Review in 2015 and Corona Virus Stock Review in January of 2020!
We added Novavax (NVAX) at $7.80, it went to $319 up 3,989% and Moderna (MRNA) at $21, which went to $485 up 2,209% – to the Corona Virus Stock Review – way ahead of those crowds.
The Guide to 46 Companies is $79, but free to subscribers of the Biotech Stock Review.
2021 PSYCHEDELIC INVESTOR GUIDE
SUBSCRIBE
– Report: Ehave Inc (EHVVF) Our Favorite Small Psychedelic Company
What exactly is a favorite?
Read More
– Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide
The Psychedelic Investor Guide is the most comprehensive and easy to use guide covering the Psychedelic sector. Up to 46 of the top companies are listed with charts, basic financial information, basic business description, and their six most recent headlines, with links to the press releases. Also included are direct links to each Company’s investor relations page and a direct link to their SEC or Sedar filings page. Everything an investor needs to get acquainted with the emerging leaders.
Read More
– OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
Such a great idea, here’s a reminder.
Without disrupting legacy sales – CEO Shai Lustgarten’s new strategy’s success are readily apparent as witnessed by both actual and projected sales growth. Sales when the strategy was first deployed were $56 million in 2018, $57 million in 2019, $60 million for TTM, and are estimated to cross the $100 million mark next year. Read More
– Billion Dollar Aggregators Buying Mom-and-Pop Amazon Sellers. Simply Amazing.
At least 77 Amazon aggregators have raised roughly $10 billion in total since April 2020, according to Marketplace Pulse.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. CBSC, MITI, EHVVF and OMQ are clients. See reports for detailed disclosure and disclaimer information. We are being retained by the companies for progress reporting.
